Tell everyone you meet this week about the organ donor register and save lives
including cancer, vaccines, a review of measures regulating the prices of medicinal products, health in the Mediterranean area, and work with health care organisations. Read more…
Despite no specific mention of liver disease, this is a huge part of the Horizon 2020 agenda so research projects linking liver disease to diabetes or retinal disease should be considered. Read more....
Now 4028 members from 106 countries
EASL Basic School of Hepatology Course 9: Epithelial Mesenchymal Interactions In Liver Development, Diseases And Cancer
Venue and dates
January 24-25, 2014
Milan, Italy
Course organisers
Prof. D. Schuppan, Mainz, Germany
Prof. M. Strazzabosco, Milan, Italy

Application for the Basic School is now closed.

This School of Hepatology will focus on the mechanisms that regulate the functional interactions between epithelial liver cells, in particular chhdlangiocytes, hepatic progenitor cells on one side, and mesenchymal and inflammatory cells, such as macrophages, on the other side. The histogenesis and cell fate of epithelial and mesenchymal cells during liver repair is an area of current controversy and clarification of definitions and further experimental evidence, as well as a clear understanding of the available experimental models and their limitation is needed. Additionally, the prospects for therapy of chronic liver diseases and liver cancer based on the presented mechanism will be discussed, also taking into account new biotechnological advances.

• Highlight novel mechanistic insights
• Delineate future avenues of research on and interventions in biliary diseases
• Booster collaborative effortsThis School of Hepatology will focus on the mechanisms that regulate the functional interactions between epithelial liver cells, in particular cholangiocytes, hepatic progenitor cells on one side, and mesenchymal and inflammatory cells, such as macrophages, on the other side. The histogenesis and cell fate of epithelial and mesenchymal cells during liver repair is an area of current controversy and clarification of definitions and further experimental evidence, as well as a clear understanding of the available experimental models and their limitation is needed. Additionally, the prospects for therapy of chronic liver diseases and liver cancer based on the presented mechanism will be discussed, also taking into account new biotechnological advances.

The sessions will be interactive and enough time will be devoted to the discussion of methodological details, covering the following objectives:

  • Provide a state of the art, overview of the field, with particular emphasis on development, the spectrum of biliary diseases, liver repair, fibrosis and cancer
  • Understand the different models, their relative advantages and limitations
  • Highlight novel mechanistic insights
  • Delineate future avenues of research on and interventions in biliary diseases
  • Booster collaborative efforts

Application for the EASL Schools of Hepatology is free.

For selected applicants, EASL will cover transportation costs to attend the school and accommodation during the event (details will be provided individually once the selection process has been done).

Application is open to young fellows under the age of 35 and/or still in training.

Approximately 30 places are available for each school and priority is given to registered EASL members during the selection process.

EASL Schools of Hepatology cover diverse aspects in the field of hepatology.
The course is divided into a balanced blend of lectures on theoretical, practical and clinical case-based discussions presented during a residential course with limited attendance.

Each school allows time for:

  • Intense interaction
  • Time for personal discussion
  • Exchanges with a distinguished faculty


The schools contribute to the training of new generations of hepatologists and are a major element of our association. Aimed at young fellows enrolled in hepatology-oriented departments or more experienced clinicians who want to be exposed to the newest trends in hepatology.

CME Accrediation

The 'EASL Basic School of Hepatology Course 9: Epithelial mesenchymal interactions in liver development in liver disease and cancer' is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.

The 'EASL Basic School of Hepatology Course 9: Epithelial mesenchymal interactions in liver development in liver disease and cancer' is designated for a maximum of (or 'for up to') 8 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.

 

Application Deadline:
October 26, 2013

 

EASL premium sponsors

Share